BioSpace News Archive

Pharnext: Findings on Symptom Burden of Charcot-Marie-Tooth Disease Type 1A From ‘Real-World’ Digital Lifestyle Study

Pharnext SA announces that findings on the symptom burden of Charcot-Marie-Tooth Disease Type 1A from the ‘Real-World’ Digital Lifestyle Study, CMT&Me, will be presented in three poster presentations at the upcoming American Association of Neuromuscular & Electrodiagnostic Medicine 2022.

September 15, 2022
·
4 min read
Biotech Beach

ViaDerma Successfully Completes Quality Control Testing of its New Vitastem Products

ViaDerma, Inc., announces the successful completion of its internal quality control testing for their new Vitastem products.

September 15, 2022
·
2 min read
Rejuvenation Startup Summit 2022 announces Program and Speakers

The Forever Healthy Foundation is pleased to announce the Rejuvenation Startup Summit 2022 program and full speaker list.

September 15, 2022
·
4 min read
Hexvix®, A Diagnostic Drug of Asieris, is Now Covered by the 2022 Lecheng Global Specialty Drug Insurance

Asieris Pharmaceuticals announced that Hexvix®, a drug used for bladder cancer diagnosis, has been included in the 2022 edition of the Lecheng Global Specialty Drug Insurance Specialty Drug List.

September 15, 2022
·
4 min read
Drug Development

BrainStorm Cell Therapeutics Announces Peer Reviewed Publication of Results from the NurOwn® Phase 2 Progressive MS Trial in Multiple Sclerosis Journal

BrainStorm Cell Therapeutics Inc. announced the peer reviewed publication of data from the Phase 2 trial of NurOwn in progressive multiple sclerosis in Multiple Sclerosis Journal.

September 15, 2022
·
11 min read
Pharm Country

Oppenheimer Hires Joel Sendek As Head of Healthcare Life Sciences Research Team, Further Bolstering the Firm’s Commitment to an Important Area of Focus

Oppenheimer & Co. Inc. announced the ongoing expansion of its Healthcare Life Sciences Research Team within the firm’s Equity Research Department with the appointment of Joel Sendek as Managing Director and Head of Healthcare Life Sciences Equity Research.

September 15, 2022
·
4 min read
Shanghai Public Health Clinical Center Completed Patient Enrollment in Clinical Study of PD-L1 Antibody ASC22 (Envafolimab) in Combination with Chidamide for Functional Cure of HIV Infection

Ascletis Pharma Inc. announces that the clinical study of PD-L1 antibody ASC22 in combination with Chidamide for functional cure of human immunodeficiency virus infection has completed the enrollment of 15 HIV infected patients.

September 15, 2022
·
4 min read
Pharm Country

Co-Author of the Karolinska 1000 Consecutive MANTA® Vascular Closure Device Study to Present Learnings at the Transcatheter Cardiovascular Therapeutics (TCT) 2022 Conference

Teleflex Incorporated announced that Dr. Magnus Settergren*, Asssociate Professor at the Karolinska Institutet, Interventional Cardiologist at Karolinska University Hospital is scheduled to present at a Teleflex-sponsored Training Pavilion at the Transcatheter Cardiovascular Therapeutics conference.

September 15, 2022
·
5 min read
Business

Caris Life Sciences Announces Appointment of Russ Denton as General Counsel

Caris Life Sciences® announced that Russ Denton has joined the company as Senior Vice President, General Counsel and Secretary, and will lead Caris’ legal and corporate governance efforts.

September 15, 2022
·
2 min read
Business

Quest Diagnostics Teams Up With Lee Health to Deliver High-Value, Innovative Laboratory Services

Quest Diagnostics, the world’s leading provider of diagnostic information services, and Lee Health, Southwest Florida’s primary community-owned health system, are teaming up to enhance the quality and value of diagnostic services to patients and their doctors.

September 15, 2022
·
2 min read